Metlife (MET) EPS (Weighted Average and Diluted) (2016 - 2026)
Metlife's EPS (Weighted Average and Diluted) history spans 18 years, with the latest figure at $1.74 for Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) rose 35.94% to $1.74 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.16 through Mar 2026, down 15.96% year-over-year, with the annual reading at $4.71 for FY2025, 20.71% down from the prior year.
- EPS (Weighted Average and Diluted) came in at $1.74 for Q1 2026, up from $1.17 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.96 in Q4 2022 to a low of $0.02 in Q1 2023.
- The 5-year median for EPS (Weighted Average and Diluted) is $1.22 (2025), against an average of $1.21.
- Year-over-year, EPS (Weighted Average and Diluted) plummeted 98.94% in 2023 and then skyrocketed 5400.0% in 2024.
- Metlife's EPS (Weighted Average and Diluted) stood at $1.96 in 2022, then crashed by 60.71% to $0.77 in 2023, then soared by 129.87% to $1.77 in 2024, then tumbled by 33.9% to $1.17 in 2025, then soared by 48.72% to $1.74 in 2026.
- Per Business Quant, the three most recent readings for MET's EPS (Weighted Average and Diluted) are $1.74 (Q1 2026), $1.17 (Q4 2025), and $1.22 (Q3 2025).